牛牛AI助理已提取核心訊息
Abbvie Inc. officer Richard A. Gonzalez is set to sell 138,616 common shares of the company, with an aggregate market value of approximately $24.57 million, on February 28, 2024. The shares to be sold were acquired on the same date as performance shares, a form of compensation from the issuer. There is no transaction history reported for Gonzalez in the past three months prior to the notice date.
Abbvie Inc. officer Richard A. Gonzalez is set to sell 138,616 common shares of the company, with an aggregate market value of approximately $24.57 million, on February 28, 2024. The shares to be sold were acquired on the same date as performance shares, a form of compensation from the issuer. There is no transaction history reported for Gonzalez in the past three months prior to the notice date.
艾伯維公司高管理查德·岡薩雷斯定於2024年2月28日出售該公司的138,616股普通股，總市值約爲2457萬美元。待出售的股票與績效股票的收購日期相同，這是發行人提供的一種補償。在通知日期之前的過去三個月中，沒有報告岡薩雷斯的交易記錄。
艾伯維公司高管理查德·岡薩雷斯定於2024年2月28日出售該公司的138,616股普通股，總市值約爲2457萬美元。待出售的股票與績效股票的收購日期相同，這是發行人提供的一種補償。在通知日期之前的過去三個月中，沒有報告岡薩雷斯的交易記錄。
有用
沒用
